raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:276280

Hemihyperplasia-multiple lipomatosis syndrome

Synonyms: HHML

Type
Malformation syndrome
Group
Disorder
Inheritance
Not applicable
Age of onset
Childhood
Status
active

Hemihyperplasia-multiple lipomatosis syndrome is a rare, genetic overgrowth syndrome characterized by non- progressive, asymmetrical, moderate hemihyperplasia (frequently affecting the limbs) associated with slow growing, painless, multiple, recurrent, subcutaneous lipomatous masses distributed throughout entire body (in particular back, torso, extremities, fingers, axillae). Superficial vascular malformations may also be associated. Increased risk of intra-abdominal embryonal malignancies may be associated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enHemihyperplasia-multiple lipomatosis syndromeHHML
frSyndrome de la lipomatose multiple-hémihyperplasie= en
deHemihyperplasie-multiples Lipomatosis-Syndrom= en
esSíndrome de hemihiperplasia-lipomatosis múltiple= en
itSindrome da emi-iperplasia e lipomatosi multipla= en
nlHemihyperplasie - multipele lipomatose-syndroom= en
ptSíndrome de lipomatose múltipla-hemihiperplasia
plZespół przerost połowiczy-mnoga tłuszczakowatość= en
csSyndrom zahrnující hemihyperplázii a mnohočetnou lipomatózu= en
ukСиндром гемігіперплазії-множинного ліпоматозу= en
zh偏侧增生-多发性脂肪过多症综合征= en
trHemihiplazi-çoklu lipomatoz sendromu= en

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10Q87.3NTBTattributedvalidated
MONDO0017177Evalidated
UMLSC4749904Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (8):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
PIK3CADisease-causing somatic mutation(s) inAssessedHGNC:8975ENSG000001218791718343q26.32phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha24782230[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families10 casesWorldwideCase(s)Validated9781913[PMID]_20058713[PMID]_19438675[PMID]_20105568[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

19 annotations · validated 2017-05-15
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0001548Overgrowth
Frequent (79-30%)
HP:0100659Abnormality of the cerebral vasculature
HP:0004099Macrodactyly
Occasional (29-5%)
HP:00107142-4 toe syndactyly
HP:0002624Abnormal venous morphology
HP:0100763Abnormality of the lymphatic system
HP:0000105Enlarged kidney
HP:0001829Foot polydactyly
HP:0000034Hydrocele testis
HP:0040009Hyperparakeratosis
HP:0100578Lipoatrophy
HP:0008551Microtia
HP:0001012Multiple lipomas
HP:0003764Nevus
HP:0012887Ovarian serous cystadenoma
HP:0002650Scoliosis
HP:0001051Seborrheic dermatitis
HP:0100585Telangiectasia of the skin
Very rare (<4-1%)
HP:0002667Nephroblastoma

Run the differential on the 1 obligate / very frequent terms

Annotation source: 24782230[PMID]_25557259[PMID]_25915946[PMID]

7

Sources for this card